- Home
- CPRI vs AGIO Comparison
CPRI vs AGIO Comparison
Compare CPRI & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRI
- AGIO
- Stock Information
- Founded
- CPRI 1981
- AGIO 2007
- Country
- CPRI United Kingdom
- AGIO United States
- Employees
- CPRI N/A
- AGIO N/A
- Industry
- CPRI Apparel
- AGIO Biotechnology: Pharmaceutical Preparations
- Sector
- CPRI Consumer Discretionary
- AGIO Health Care
- Exchange
- CPRI Nasdaq
- AGIO Nasdaq
- Market Cap
- CPRI 2.2B
- AGIO 2.4B
- IPO Year
- CPRI 2011
- AGIO 2013
- Fundamental
- Price
- CPRI $22.32
- AGIO $43.29
- Analyst Decision
- CPRI Buy
- AGIO Strong Buy
- Analyst Count
- CPRI 12
- AGIO 4
- Target Price
- CPRI $24.08
- AGIO $59.33
- AVG Volume (30 Days)
- CPRI 2.0M
- AGIO 519.0K
- Earning Date
- CPRI 11-07-2025
- AGIO 10-30-2025
- Dividend Yield
- CPRI N/A
- AGIO N/A
- EPS Growth
- CPRI N/A
- AGIO N/A
- EPS
- CPRI N/A
- AGIO 11.13
- Revenue
- CPRI $4,391,000,000.00
- AGIO $40,875,000.00
- Revenue This Year
- CPRI N/A
- AGIO $23.74
- Revenue Next Year
- CPRI $3.83
- AGIO $159.90
- P/E Ratio
- CPRI N/A
- AGIO $3.89
- Revenue Growth
- CPRI N/A
- AGIO 30.57
- 52 Week Low
- CPRI $11.86
- AGIO $23.42
- 52 Week High
- CPRI $42.21
- AGIO $62.58
- Technical
- Relative Strength Index (RSI)
- CPRI 60.71
- AGIO 63.01
- Support Level
- CPRI $18.85
- AGIO $41.24
- Resistance Level
- CPRI $22.98
- AGIO $43.67
- Average True Range (ATR)
- CPRI 0.86
- AGIO 1.48
- MACD
- CPRI 0.24
- AGIO 0.05
- Stochastic Oscillator
- CPRI 85.84
- AGIO 86.18
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.
About AGIO Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.